HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.

AbstractUNLABELLED:
Recently, the single nucleotide polymorphism (SNP) identified as rs1260326, in the glucokinase regulatory protein (GCKR), was associated with hypertriglyceridemia in adults. Because accumulation of triglycerides in hepatocytes represents the hallmark of steatosis, we aimed to investigate whether this variant might be associated with fatty liver (hepatic fat content, HFF%). Moreover, because recently rs738409 in the PNPLA3 and rs2854116 in the APOC3 were associated with fatty liver, we explored how the GCKR SNP and these two variants jointly influence hepatosteatosis. We studied 455 obese children and adolescents (181 Caucasians, 139 African Americans, and 135 Hispanics). All underwent an oral glucose tolerance test and fasting lipoprotein subclasses measurement by proton nuclear magnetic resonance. A subset of 142 children underwent a fast gradient magnetic resonance imaging to measure the HFF%. The rs1260326 was associated with elevated triglycerides (Caucasians P = 0.00014; African Americans P = 0.00417), large very low-density lipoprotein (VLDL) (Caucasians P = 0.001; African Americans, P = 0.03), and with fatty liver (Caucasians P = 0.034; African Americans P = 0.00002; and Hispanics P = 0.016). The PNPLA3, but not the APOC3 rs2854116 SNP, was associated with fatty liver but not with triglyceride levels. There was a joint effect between the PNPLA3 and GCKR SNPs, explaining 32% of HFF% variance in Caucasians (P = 0.00161), 39.0% in African Americans (P = 0.00000496), and 15% in Hispanics (P = 0.00342).
CONCLUSION:
The rs1260326 in GCKR is associated with hepatic fat accumulation along with large VLDL and triglyceride levels. GCKR and PNPLA3 act together to convey susceptibility to fatty liver in obese youths.
AuthorsNicola Santoro, Clarence K Zhang, Hongyu Zhao, Andrew J Pakstis, Grace Kim, Romy Kursawe, Daniel J Dykas, Allen E Bale, Cosimo Giannini, Bridget Pierpont, Melissa M Shaw, Leif Groop, Sonia Caprio
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 55 Issue 3 Pg. 781-9 (Mar 2012) ISSN: 1527-3350 [Electronic] United States
PMID22105854 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 American Association for the Study of Liver Diseases.
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Apolipoprotein C-III
  • GCKR protein, human
  • Lipoproteins, VLDL
  • Membrane Proteins
  • Triglycerides
  • Lipase
  • adiponutrin, human
Topics
  • Adaptor Proteins, Signal Transducing (genetics)
  • Adolescent
  • Black or African American
  • Apolipoprotein C-III (genetics)
  • Child
  • Fatty Liver (epidemiology, ethnology, genetics)
  • Female
  • Gene Frequency (genetics)
  • Genetic Predisposition to Disease (epidemiology, ethnology, genetics)
  • Haplotypes
  • Hispanic or Latino
  • Humans
  • Lipase (genetics)
  • Lipoproteins, VLDL (blood)
  • Male
  • Membrane Proteins (genetics)
  • Obesity (blood, complications)
  • Polymorphism, Single Nucleotide (genetics)
  • Risk Factors
  • Triglycerides (blood)
  • White People

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: